In vivo, biguanides inhibit local and metastatic growth of triple negative and HER2+breast cancer in immune-competent and immune-deficient orthotopic mice models. Biguanides inhibit local and metastatic breast cancer growth in a genetically engineered murine model of HER2+breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.